These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19333889)

  • 1. 27th Annual JPMorgan Healthcare Conference--Prism and Medarex.
    Croasdell G
    IDrugs; 2009 Mar; 12(3):142-4. PubMed ID: 19333889
    [No Abstract]   [Full Text] [Related]  

  • 2. 27th Annual JPMorgan Healthcare Conference--Ablynx and Facet Biotech.
    Mason VL
    IDrugs; 2009 Mar; 12(3):137-9. PubMed ID: 19333887
    [No Abstract]   [Full Text] [Related]  

  • 3. 27th Annual JPMorgan Healthcare Conference--Antisoma and Keryx Biopharmaceuticals.
    Croasdell G; Gale S
    IDrugs; 2009 Mar; 12(3):152-4. PubMed ID: 19333892
    [No Abstract]   [Full Text] [Related]  

  • 4. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions.
    Croasdell G; Gale S
    IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891
    [No Abstract]   [Full Text] [Related]  

  • 5. 27th Annual JPMorgan Healthcare Conference--Gilead and Endo Pharmaceuticals.
    Gale S; Mason VL
    IDrugs; 2009 Mar; 12(3):145-8. PubMed ID: 19333890
    [No Abstract]   [Full Text] [Related]  

  • 6. 27th Annual JPMorgan Healthcare Conference--Biogen Idec.
    Gale S
    IDrugs; 2009 Mar; 12(3):140-1. PubMed ID: 19333888
    [No Abstract]   [Full Text] [Related]  

  • 7. JPMorgan--26th annual healthcare conference. Part 2.
    Chan D
    IDrugs; 2008 Mar; 11(3):156-8. PubMed ID: 18311645
    [No Abstract]   [Full Text] [Related]  

  • 8. JPMorgan--26th annual healthcare conference. Part 1.
    Chan D
    IDrugs; 2008 Mar; 11(3):153-5. PubMed ID: 18311644
    [No Abstract]   [Full Text] [Related]  

  • 9. 28th Annual JPMorgan Healthcare Conference--Exelixis and Nektar Therapeutics.
    Gale S; Croasdell G
    IDrugs; 2010 Mar; 13(3):139-41. PubMed ID: 20191424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 28th Annual JPMorgan Healthcare Conference--Human Genome Sciences and Celgene.
    Gale S; Croasdell G
    IDrugs; 2010 Mar; 13(3):135-8. PubMed ID: 20191423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American society of clinical oncology - 45th annual meeting. Part 2.
    Lakeram M; Kibble A
    IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
    [No Abstract]   [Full Text] [Related]  

  • 12. American society of clinical oncology - 45th annual meeting. Part 1.
    Gale S
    IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant trials could speed up drug approvals.
    Peres J
    J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911
    [No Abstract]   [Full Text] [Related]  

  • 14. 28th Annual JPMorgan Healthcare Conference--Affymax and Infinity Pharmaceuticals.
    Croasdell G; Mason VL
    IDrugs; 2010 Mar; 13(3):142-4. PubMed ID: 20191425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the analyst's couch: Next-generation antibodies.
    Evans JB; Syed BA
    Nat Rev Drug Discov; 2014 Jun; 13(6):413-4. PubMed ID: 24722461
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinued drugs in 2008: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First new lupus drug approved in half-century.
    Thompson CA
    Am J Health Syst Pharm; 2011 Apr; 68(8):646. PubMed ID: 21460166
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical approval success rates for investigational cancer drugs.
    DiMasi JA; Reichert JM; Feldman L; Malins A
    Clin Pharmacol Ther; 2013 Sep; 94(3):329-35. PubMed ID: 23739536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial transparency: registries, databases raise questions, stir debate.
    Benowitz S
    J Natl Cancer Inst; 2005 Nov; 97(22):1640-1. PubMed ID: 16288115
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging chemotherapeutic strategies for Huntington's disease.
    Ryu H; Ferrante RJ
    Expert Opin Emerg Drugs; 2005 May; 10(2):345-63. PubMed ID: 15934871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.